I Present Address: Massachusetts General Hospital, Boston, Massachusetts, U.S.A. § Present Address: University Department of Medicine, Royal Infirmary, Glasgow, C.4., Scotland. several workers have noted the frequent occurrence of thyroglobulin auto-antibodies in patients with the condition (Bloch, Bunim, and others, 1960; Bloch, Wohl, and others, 1960; Anderson, Goudie, Gray, and Buchanan, 1961; Bunim, 1961) . The present paper describes the prevalence of several systems of antinuclear and precipitating auto-antibodies in relation to the clinical and laboratory findings in a series of well-documented cases of Sjogren's syndrome. Materials and Methods Patients.-42 patients (40 females, 2 males), from various parts of the United States, suffering from Sjogren's syndrome, were studied at the National Institutes of Health. Patients were included in the study only when at least two of the three major components of Sjogren's syndrome could be demonstrated: connective tissue disease (rheumatoid arthritis or other), keratoconjunctivitis sicca, and salivary gland involvement. Patients in whom the sicca syndrome could be attributed to sarcoidosis, macroglobulinaemia of Waldenstrom, leukaemia, and lymphoma were excluded. The diagnosis of rheumatoid arthritis was based on the criteria of the American Rheumatism Association (Ropes, Bennett, Cobb, Jacox, and Jessar, 1959) .
The 42 patients with Sjogren's syndrome were separated into five clinical groups: Group A Eighteen patients with Sjogren's syndrome SJOGREN'S SYNDROME Group D Three patients with Sjogren's syndrome and myopathy.
Group E Sixteen patients with Sjogren's syndrome with characteristic ocular and oral findings but without evidence of rheumatoid arthritis or other connective tissue disease.
Serological Methods.-Antinuclear antibodies were detected by the indirect fluorescent antibody technique, using cryostat sections of unfixed rat liver by the method described previously (Beck, 1961) . The sections were examined under dark-field ultra-violet/blue violet light with a horizontal optical system of the type described by Young (1961) . With the technique used in this laboratory, the fluorescent antibody test for antinuclear antibodies was considered positive only when nuclear staining was obtained with sera diluted 1/16 with saline. This level was arbitrarily chosen as the test was positive at 1/16 dilution in only 4 per cent. of a series of 500 hospital patients (none of whom was known to suffer from a connective tissue disease) but was positive in 27 per cent. if sera were used at 1/4 dilution and in 46 per cent. if undiluted serum was used (Beck, 1963) . All positive sera were titrated at four-fold dilutions. The pattern of nuclear staining was recorded in each case using the terminology described previously (Beck, 1961 (Beck, , 1962 (Beck, , 1963 as follows:
Homogenteous. Each nucleus was stained throughout, often with central large irregular areas of somewhat more intense staining, but the nucleoli were unstained.
Speckleck.-Numerous minute points of fluorescence were seen in each nucleus so that the margin was indistinct. Nucleolar.-Each nucleolus was uniformly stained, its smooth surface sharply demarcated from the adjacent nucleus, and the heterochromatin was unstained.
Membranious.-Individual nuclei in the section were stained with varying intensity; most showed a narrow band of brighter staining at the surface and the heterochromatin was prominent. Investigations on the corresponding antigens have shown that the homogeneous antigen is nucleohistone (DNA-histone) and that the speckled antigen is a saline soluble protein, with a sedimentation coefficient between 3-5S and 2 OS. The nucleolar antigen has not been identified but is probably a protein associated with nucleolar RNA. The membranous antigen is DNA (Beck, 1961 (Beck, , 1962 (Beck, , 1963 .
It must be noted that many sera give a mixed pattern of staining at high concentration, but show a characteristic staining pattern near the end-point in the titration. This indicates that a mixture of antibodies of different specificities is present in the serum; only the antibody present in highest titre can be identified conclusively, with the reservation that it is usually possible to identify the pattern of nuclear staining accompanying nucleolar staining.
Precipitating auto-antibodies reacting with saline extracts of various human tissues were detected by an agar diffusion Ouchterlony plate method, as described by Anderson, Gray, and others (1961) and Anderson, Gray, Beck, Buchanan, and McElhinney (1962) . Using this technique, four separate antigen-antibody systems were identified in a large series of patients with Sjogren's syndrome, systemic lupus erythematosus, rheumatoid arthritis, and other connective tissue diseases (Anderson, Gray, and others, 1961, 1962) , The antibodies (designated anti-SjD, anti-SjT, anti-DNA, and anti-Lup respectively) ranged in titre up to 1 in 512 and had the characteristic mobility of gamma globulin on immuno-electrophoresis. Three of the antibodies (anti-SjD, anti-SjT, and anti-DNA) were shown by ultracentrifugation to have sedimentation coefficients of 7S (Anderson and others, 1962) . The antigens involved were unidentified specific cellular constituents present in a variety of human tissue extracts, (Anderson and others, 1962) . One of the antigens was identified as DNA, but the three other antigens are trace constituents of cell extracts which have not been identified. Examples of anti-SjT, antiSjD, and anti-DNA were shown to react with the patient's own tissues. The L.E.-cell test used was that developed by Zinkham and Conley (1956 ). The sera were tested for the presence of rheumatoid factor by the Bentonite flocculation test and the sensitized sheep cell agglutination test, using the methods described by Bozicevich, Bunim, Freund, and Ward (1958) and Ziff, Brown, Lospalluto, Badin, and McEwen (1956) respectively. The tanned red cell agglutination test was used to detect anti-thyroglobulin (Roitt and Doniach, 1958) , and the auto-immune complementfixation reaction using human liver as antigen was detected by the method used by Bloch, Wohl, and others (1960 and this was due mainly to the higher indicence of "speckled" antinuclear antibody and the occurrence of antinucleolar antibody in Group E: the incidence of "homogeneous" antinuclear antibody was the same in both groups. Antinucleolar antibody was not encountered in Group A, although present in one patient with "probable" rheumatoid arthritis in Group B. The "membranous" staining pattern was not given by any of the sera tested in this study.
The titres of antinuclear antibodies found in patients of Groups A and E are compared in Fig. 1 . The titres of the different systems of antinuclear antibodies in Group A and E are compared in Fig. 2 . These histograms show that higher titres were encountered in Group E as well as the higher incidence and greater variety of antinuclear antibodies described above.
No relationship was found between the age of the patient, the duration of the disease, or the presence of kerato-conjunctivitis sicca or xerostomia, and the presence or titre of antinuclear antibodies in the whole series or in any sub-group. The number of male patients in the series was too small (only two cases) to allow deductions on the relative incidence A'omogeneous LI SJOGREN'S SYNDROME in males and females. There was, however, a direct relationship to the presence of parotid gland enlargement by history or on examination. Thus, of 22 patients with parotid gland enlargement, nineteen had antinuclear antibodies, whereas only ten of twenty patients with no parotid enlargement had positive antinuclear factor tests (X2 = 4-893; P <0 05).
All patients with positive L.E.-cell tests showed high titre "homogeneous" antinuclear antibody, but the converse did not hold. There was no direct relationship between the results of the fluorescent antibody test for antinuclear antibodies and the other immunological reactions such as the Bentonite flocculation test and sensitized sheep cell agglutination test for rheumatoid factor, anti-thyroglobulin, and the auto-immune complement-fixation reaction. The mean y-globulin level in patients with antinuclear antibodies (2-357 g./l00 ml.) was significantly greater (P <0 01) than in patients without antinuclear antibodies (1 514 g./l00 ml.).
Precipitating Auto-antibodies Table II lists the frequency and type of precipitins encountered in this study. As in previous investigations (Anderson, Gray, and others, 1961, 1962) , the most commonly detected precipitins in Sjogren's syndrome were anti-SjD and anti-SjT, although anti-Lup was detected in three sera. Failure to detect anti-DNA corresponds with the absence of the nuclear membrane type of staining in the immuno-fluorescent tests. The other three precipitins do not appear to correspond to any of the other patterns of nuclear staining. The incidence of positive precipitin tests was significantly higher in Group E than in Group A patients (x2 -10.9; P <0 001) and two distinct precipitins were commonly found in Group E sera.
Discussion
Antinuclear antibodies were detected in 28 of our 42 cases of Sj6gren's syndrome (67 per cent.). This incidence is somewhat lower than that encountered using the same methods in systemic lupus erythematosus (82 per cent.) and progressive systemic sclerosis (81 per cent.), but is higher than that seen in chronic discoid lupus erythematosus (35 per cent.) and uncomplicated rheumatoid arthritis (24 per cent.) (Beck, 1963) . There have been few previous observations on the occurrence of antinuclear antibodies in Sjogren's syndrome and none of them have distinguished the different patterns of nuclear fluorescence. Thompson (1962) and Vanselow and others (1963) tested small groups of patients and found antinuclear antibodies in two of six and two of five cases respectively. Bloch, Bunim, and others (1960) investigated thirty patients (some of them are included in the present series) and detected antinuclear antibodies in 21; the prevalence in patients with rheumatoid arthritis (Group A) and without rheumatoid arthritis (Group E) was eight of thirteen and eleven of twelve respectively. Thus the increased prevalence of antinuclear antibodies in Group E had been recognized, but the increased variety of antinuclear antibodies in these patients had not been known previously.
In the whole series of cases of Sjogren's syndrome, the ratio of the prevalence of "homogeneous" to "speckled" antinuclear antibodies (H: S ratio) was 1 5. This is somewhat lower than that found in (Beck, 1963) . Antinucleolar antibodies were not detected in Group A, nor were they seen in a previous study of rheumatoid arthritis (Beck, Anderson, McElhinney, and Rowell, 1962) . Antinucleolar antibody was seen in 33 per cent. of the patients in Group E with the sicca syndrome unaccompanied by a major connective tissue disease, and this is higher than the incidence observed in progressive systemic sclerosis (19 per cent.), systemic lupus erythematosus (1 5 per cent.), and chronic discoid lupus erythematosus (0 67 per cent.) (Beck and others, 1962) . Consideration of the titres of antinuclear antibodies found in patients in Group A and E (Fig. I) has shown that high titres are much commoner in Group E.
The precipitating antibodies were more common and often of higher titre in Group E than in Group A patients (P <0 001) ( Table II) . The corresponding antigens could not be identified because they were present in trace quantities in tissue extracts and were unstable on chemical manipulation. The occurrence of three distinct precipitins regarded as auto-antibodies adds to the complexity of the autoimmune phenomena of Sjogren's syndrome, for, in addition to the antinuclear antibodies already discussed, Deicher and others (1960) (Group D) , and sixteen had the sicca syndrome alone (Group E).
Of the 42 patients, 28 (67 per cent.) had positive antinuclear factor tests, the incidence and titre of the antibodies being greater in patients of Group E than in Group A. There was a direct relationship between the presence of antinuclear factor and parotid enlargement indicated by history or examination, and a direct relation between the titres of antinuclear factor and the gamma globulin levels.
Study of the morphological pattern of nuclear fluorescence showed that the prevalence of "homogeneous" antibody, was the same in Groups A and E, but that "speckled" antinuclear antibody was more common in Group E.
With the exception of one patient with "probable" rheumatoid arthritis (Group B), antinucleolar antibody was found exclusively in patients of Group E. "Membranous" antinuclear antibody (anti-DNA) was not detected in any of the sera. All patients with positive L.E.-cell tests had high titre "homogeneous" antinuclear antibody, but the converse did not hold.
Precipitating auto-antibodies reacting with saline extracts of various human tissues were detected by an agar diffusion Ouchterlony plate method in eighteen of the 42 patients (43 per cent.). Three distinct precipitating auto-antibodies were found (anti-SjD, anti-SjT, and anti-Lup). As with the antinuclear antibodies, the incidence and titre of the precipitating auto-antibodies were higher in Group E than Group A. 
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ANNALS OF THE RI L'examen de l'image morphologique de la fluorescence nucieaire montra que la frequence de l'anticorps "homogene" fut la meme dans les Groupes A et E, mais que l'anticorps antinuckaire "tachete" fut plus commun dans le Groupe E. A l'exception d'un malade atteint d'arthrite rhumatismale "probable" (Groupe B), l'anticorps antinuckaire fut trouve exclusivement chez des malades du Groupe E. L'anticorps antinuckaire "membraneux" (anti-ADN) ne fut decek dans aucun serum. Tous les malades accusant le phenomene L.E. eurent un titre eleve de l'anticorps antinuckaire mais le reciproque ne fut pas vrai.
Les auto-anticorps precipitants, reagissant avec des extraits en l'eau physiologique de differents tissus humains, furent deceles par la methode d'Ouchterlony (plaques de diffusion sur agar) chez 18 sur 42 malades (43 pour cent). On trouva trois differents auto-anticorps (anti-SjD, anti-SjT, et anti-Lup). Comme pour les anticorps antinucleaires, la frequence et les titres des auto-anticorps furent superieurs dans le Groupe E que dans le Groupe A.
Auto-anticuerpos antinucleares y precipitantes en el sindrome de Sjogren SUMARIO Se determinaron los anticuerpos antinucleares por el procedimiento de fluorescencia indirecta en 42 enfermos con sindrome de Sjogren. Entre estos enfermos hubo 18 casos de artritis reumatoide (Grupo A), 2 casos de (EUMATIC DISEASES artritis reumatoide probable (Grupo B), 3 casos de esclerosis diseminada progresiva (Grupo C), 3 casos de polimiositis (Grupo D), y 16 casos de sindrome sicca solo (Grupo E). En 28 (67 por ciento) de los 42 enfermos el test para el factor antinuclear fue positivo; su frecuencia y el titulo de los anticuerpos fueron mayores en los enfermos del Grupo E que en los del Grupo A. Se not6 una raz6n directa entre la presencia del factor antinuclear y de la hipertofia parotidea, presente o pasada asi como una raz6n directa entre la concentracion del factor antinuclear y el nivel de la globulina gamma.
Un examen del aspecto morfol6gico de la fluorescencia nuclear revel6 que la frecuencia del anticuerpo "homogeneo" fue igual en los Groups A y E, pero el anticuerpo antinuclear "moteado" fue mas comuin en el Grupo E. Con excepci6n de un enfermo con artritis reumatoide "probable" (Grupo B), el anticuerpo antinuclear fue encontrado exclusivamente en enfermos del Grupo E. El anticuerpo antinuclear "membranoso" (anti-ADN) no fue observado en ninguin suero. Todos los enfermos con celulas L.E. acusaron cifras altas del anticuerpo antinuclear, pero no hubo relaci6n reciproca.
Los auto-anticuerpos precipitantes, que reaccionaban con extractos de differentes tejidos humanos en soluci6n salina, fueron evidenciados por el metodo de Ouchterlony (difusion sobre placas con agar) en 18 de los 42 enfermos (43 por ciento). Encontraronse tres diferentes autoanticuerpos (anti-SjD, anti-SjT, y anti-Lup). Como en el caso de los anticuerpos antinucleares, la frecuencia y la concentraci6n de los auto-anticuerpos fueron superiores en el Grupo E que en el Grupo A.
